Publications by authors named "Jay Herson"

Claim this Profile
I
Is the pendulum slowly starting to swing back?
Michael S Ewer, Jay Herson

Cardiooncology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggregate IND Safety Reporting for Smaller Companies and Programs.
Greg Ball, Mengchun Li, Jim Buchanan, Barbara Hendrickson, Richard C Zink, Jay Herson

Ther Innov Regul Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anticancer Treatments: Do the Data Support the Recommendations?
Michael S Ewer, Nicolas L Palaskas, Jay Herson

J Pharmacol Exp Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports.
Michael S Ewer, Jay Herson

Cardiooncology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial.
Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson

Breast· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson

Breast Cancer Res Treat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial preparations for the next pandemic.
Jay Herson

Contemp Clin Trials· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False Positive Cardiotoxicity Events in Cancer-Related Clinical Trials: Risks Related to Imperfect Noninvasive Parameters.
Michael S Ewer, Jay Herson

Chemotherapy· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
Hope S Rugo, Abhijit Barve, Cornelius F Waller, Miguel Hernandez-Bronchud, Jay Herson

JAMA· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for dealing with fraud in clinical trials.
Jay Herson

Int J Clin Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees.

Clin Trials· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
Dennis S Charney, Charles B Nemeroff, Lydia Lewis, Sally K Laden, Jack M Gorman, Jay Herson

Arch Gen Psychiatry· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis